Status:
COMPLETED
A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
Lead Sponsor:
China-Japan Friendship Hospital
Collaborating Sponsors:
LinkDoc Technology (Beijing) Co. Ltd.
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
65+ years
Brief Summary
The trial was designed to compare effectiveness and safety of surgeries in the patients with non-small cell lung cancer
Detailed Description
The trial is a multi-centre, real-world, non-interventional, observational study. The Chinese elderly pathologically diagnosed patients with early-stage non-small cell lung cancer enrolled from 2015 t...
Eligibility Criteria
Inclusion
- Patients who received surgeries from 2014 to 2017;
- Patients who received lobectomy or segment/wedge dissection;
- Pathologically diagnosed patients with non-small cell lung cancer;
- Patients with age \>=65 years old.
Exclusion
- Patients who received neoadjuvant therapy prior to surgery.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
10885 Patients enrolled
Trial Details
Trial ID
NCT03429673
Start Date
December 1 2017
End Date
March 30 2018
Last Update
May 21 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
China People's Liberation Army Hospital
Beijing, Beijing Municipality, China, 100853
3
Henan Cancer Hospital
Zhengzhou, Henan, China, 450008
4
Tongji Hospital Affiliated to Huaxi Technology University
Wuhan, Hubei, China, 430030